Solving COVID: July 1, 2020

A new immunity therapy is tested in Scotland, UV light could make indoor spaces safe, and more

Syringes.
(Image credit: Illustrated | iStock)

1. Scotland tests COVID-19 therapy to boost immune response early in infection

A Scottish biotech firm called TC BioPharm has won approval to test an experimental T-cell injection therapy to fight COVID-19 by boosting the immune system early in a coronavirus infection, the Financial Times reports. The six-month trial in Edinburgh will involve harvesting T-cells from healthy people, cultivating a large number of the cells in a lab, then injecting the donor cells into hospitalized patients. A large enough infusion could head off the infection before the patient needs to move to intensive care, and even prevent cytokine storms that ravage patients whose bodies mount an overly aggressive immune response. "We have got some evidence that if you kill the virus effectively early on, then [there] should be no reason for the host to have this overwhelming response," Dr. Nik Hirani at Edinburgh University's Center for Inflammation Research tells FT. T-cells decrease in number as people get older, so the injections might be especially helpful for elderly patients.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More